Identifying Allelic Loss and Homozygous Deletions in Pancreatic Cancer without Matched Normals Using High-Density Single-Nucleotide Polymorphism Arrays
Open Access
- 15 August 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (16) , 7920-7928
- https://doi.org/10.1158/0008-5472.can-06-0721
Abstract
Recent advances in oligonucleotide arrays and whole-genome complexity reduction data analysis now permit the evaluation of tens of thousands of single-nucleotide polymorphisms simultaneously for a genome-wide analysis of allelic status. Using these arrays, we created high-resolution allelotype maps of 26 pancreatic cancer cell lines. The areas of heterozygosity implicitly served to reveal regions of allelic loss. The array-derived maps were verified by a panel of 317 microsatellite markers used in a subset of seven samples, showing a 97.1% concordance between heterozygous calls. Three matched tumor/normal pairs were used to estimate the false-negative and potential false-positive rates for identifying loss of heterozygosity: 3.6 regions (average minimal region of loss, 720,228 bp) and 2.3 regions (average heterozygous gap distance, 4,434,994 bp) per genome, respectively. Genomic fractional allelic loss calculations showed that cumulative levels of allelic loss ranged widely from 17.1% to 79.9% of the haploid genome length. Regional increases in “NoCall” frequencies combined with copy number loss estimates were used to identify 41 homozygous deletions (19 first reports), implicating an additional 13 regions disrupted in pancreatic cancer. Unexpectedly, 23 of these occurred in just two lines (BxPc3 and MiaPaCa2), suggesting the existence of at least two subclasses of chromosomal instability (CIN) patterns, distinguished here by allelic loss and copy number changes (original CIN) and those also highly enriched in the genomic “holes” of homozygous deletions (holey CIN). This study provides previously unavailable high-resolution allelotype and deletion breakpoint maps in widely shared pancreatic cancer cell lines and effectively eliminates the need for matched normal tissue to define informative loci. (Cancer Res 2006; 66(16): 7920-9)Keywords
All Related Versions
This publication has 44 references indexed in Scilit:
- A haplotype map of the human genomeNature, 2005
- Genomewide Single Nucleotide Polymorphism Microarray Mapping in Basal Cell Carcinomas Unveils Uniparental Disomy as a Key Somatic EventCancer Research, 2005
- Genotyping over 100,000 SNPs on a pair of oligonucleotide arraysNature Methods, 2004
- High-Resolution Analysis of DNA Copy Number Using Oligonucleotide MicroarraysGenome Research, 2004
- In VitroEstablishment of Tumorigenic Human B-Lymphoblastoid Cell Lines Transformed by Epstein-Barr VirusDNA and Cell Biology, 2003
- BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) Mutations in Distinct Subsets of Pancreatic CancerThe American Journal of Pathology, 2003
- Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumoursNature, 2003
- Mutation Analyses of 268 Candidate Genes in Human Tumor Cell LinesGenomics, 2001
- High-density screen of human tumor cell lines for homozygous deletions of loci on chromosome arm 8pGenes, Chromosomes and Cancer, 1999
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989